Performance enhancing drug abuse and cardiovascular risk in athletes: implications for the clinician
These include the β-2 agonist, clenbuterol (which is additionally used as an anorectic ... In these groups there is likely great heterogeneity in total AS dose, poly-drug regimens employed as well the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback